VIR
VIR
US92764N1028
Vir Biotechnology, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.98B EUR
1.72B EUR
1.44B EUR
841.03M EUR
Enterprise Value
1.44B EUR
1.54B EUR
1.27B EUR
706.7M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.7x
--
--
--
Price to Sales
6.53x
5.7x
22.33x
12.99x
Price to Book
2.01x
1.75x
1.78x
1.1x
EV/Revenue
4.76x
5.08x
19.57x
10.92x
EV/EBITDA
-5.38x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.96%
-11.81%
-31.12%
-37.68%
ende